APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prostate Cancer Diagnostics

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

Selected research

Market Structure

Global Prostate Cancer Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173895340325 December 2025191 pages

Choose your research edition.

Industry ResearchProstate Cancer Diagnostics Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostate Cancer Diagnostics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Prostate Cancer Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostate Cancer Diagnostics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostate Cancer Diagnostics Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.

Read the full market overview

Report Includes

This report provides an overview of the global Prostate Cancer Diagnostics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostate Cancer Diagnostics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostate Cancer Diagnostics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Prostate Cancer Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostate Cancer Diagnostics Segment by Company

OPKO

Genomic Health

Abbott

Beckman Coulter

Siemens Healthcare

bioMeriux

Roche

MDx Health

DiaSorin

Myriad Genetics

Ambry Genetics

Prostate Cancer Diagnostics Segment by Type

Tumor Biomarker Tests

Imaging

Biopsy

Other

Prostate Cancer Diagnostics Segment by Application

Age Below 55

Age 55-75

Age Above 75

Prostate Cancer Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Prostate Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostate Cancer Diagnostics industry.

Chapter 3: Detailed analysis of Prostate Cancer Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Cancer Diagnosticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tumor Biomarker Tests Table 3. Key Players of Imaging Table 4. Key Players of Biopsy Table 3. Key Players of Other Table 4. Global Prostate Cancer Diagnostics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Age Below 55 Table 6. Key Players of Age 55-75 Table 7. Key Players of Age Above 75 Table 8. Global Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Prostate Cancer Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Prostate Cancer Diagnostics Market Share by Region (2021-2026) Table 11. Global Prostate Cancer Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Prostate Cancer Diagnostics Market Share by Region (2027-2032) Table 13. Prostate Cancer Diagnostics Industry Trends Table 14. Prostate Cancer Diagnostics Industry Drivers Table 15. Prostate Cancer Diagnostics Industry Opportunities and Challenges Table 16. Prostate Cancer Diagnostics Industry Restraints Table 17. Global Prostate Cancer Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Prostate Cancer Diagnostics Revenue Market Share by Company (2021-2026) Table 19. Global Prostate Cancer Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Prostate Cancer Diagnostics Key Company Head Office and Area Served Table 21. Global Prostate Cancer Diagnostics Company, Product Type & Application Table 22. Global Prostate Cancer Diagnostics Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Prostate Cancer Diagnostics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Prostate Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Prostate Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2021-2026) Table 29. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2027-2032) Table 30. Global Prostate Cancer Diagnostics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Prostate Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Prostate Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2021-2026) Table 34. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2027-2032) Table 35. OPKO Company Information Table 36. OPKO Business Overview Table 37. OPKO Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. OPKO Prostate Cancer Diagnostics Product Portfolio Table 39. OPKO Recent Development Table 40. Genomic Health Company Information Table 41. Genomic Health Business Overview Table 42. Genomic Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Genomic Health Prostate Cancer Diagnostics Product Portfolio Table 44. Genomic Health Recent Development Table 45. Abbott Company Information Table 46. Abbott Business Overview Table 47. Abbott Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Abbott Prostate Cancer Diagnostics Product Portfolio Table 49. Abbott Recent Development Table 50. Beckman Coulter Company Information Table 51. Beckman Coulter Business Overview Table 52. Beckman Coulter Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Beckman Coulter Prostate Cancer Diagnostics Product Portfolio Table 54. Beckman Coulter Recent Development Table 55. Siemens Healthcare Company Information Table 56. Siemens Healthcare Business Overview Table 57. Siemens Healthcare Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio Table 59. Siemens Healthcare Recent Development Table 60. bioMeriux Company Information Table 61. bioMeriux Business Overview Table 62. bioMeriux Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. bioMeriux Prostate Cancer Diagnostics Product Portfolio Table 64. bioMeriux Recent Development Table 65. Roche Company Information Table 66. Roche Business Overview Table 67. Roche Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Roche Prostate Cancer Diagnostics Product Portfolio Table 69. Roche Recent Development Table 70. MDx Health Company Information Table 71. MDx Health Business Overview Table 72. MDx Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. MDx Health Prostate Cancer Diagnostics Product Portfolio Table 74. MDx Health Recent Development Table 75. DiaSorin Company Information Table 76. DiaSorin Business Overview Table 77. DiaSorin Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. DiaSorin Prostate Cancer Diagnostics Product Portfolio Table 79. DiaSorin Recent Development Table 80. Myriad Genetics Company Information Table 81. Myriad Genetics Business Overview Table 82. Myriad Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Myriad Genetics Prostate Cancer Diagnostics Product Portfolio Table 84. Myriad Genetics Recent Development Table 85. Ambry Genetics Company Information Table 86. Ambry Genetics Business Overview Table 87. Ambry Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Ambry Genetics Prostate Cancer Diagnostics Product Portfolio Table 89. Ambry Genetics Recent Development Table 90. North America Prostate Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Prostate Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Prostate Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Prostate Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Prostate Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Prostate Cancer Diagnostics Market Size by Country (2021-2026) Table 96. North America Prostate Cancer Diagnostics Market Size by Country (2027-2032) Table 97. Europe Prostate Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Prostate Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Prostate Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Prostate Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Prostate Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Prostate Cancer Diagnostics Market Size by Country (2021-2026) Table 103. Europe Prostate Cancer Diagnostics Market Size by Country (2027-2032) Table 104. China Prostate Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 105. China Prostate Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 106. China Prostate Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 107. China Prostate Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Prostate Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Prostate Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Prostate Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Prostate Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Prostate Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Prostate Cancer Diagnostics Market Size by Country (2021-2026) Table 114. Asia Prostate Cancer Diagnostics Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Prostate Cancer Diagnostics Product Image Figure 2. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Prostate Cancer Diagnostics Market Share by Type: 2025 VS 2032 Figure 4. Tumor Biomarker Tests Image Figure 5. Imaging Image Figure 6. Biopsy Image Figure 7. Other Image Figure 8. Global Prostate Cancer Diagnostics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Prostate Cancer Diagnostics Market Share by Application: 2025 VS 2032 Figure 10. Age Below 55 Image Figure 11. Age 55-75 Image Figure 12. Age Above 75 Image Figure 13. Global Prostate Cancer Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 15. Global Prostate Cancer Diagnostics Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Prostate Cancer Diagnostics Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Prostate Cancer Diagnostics Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Prostate Cancer Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2021-2032) Figure 22. Global Prostate Cancer Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2021-2032) Figure 24. North America Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 25. North America Prostate Cancer Diagnostics Market Share by Type (2021-2032) Figure 26. North America Prostate Cancer Diagnostics Market Share by Application (2021-2032) Figure 27. North America Prostate Cancer Diagnostics Market Share by Country (2021-2032) Figure 28. United States Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 29. Canada Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 32. Europe Prostate Cancer Diagnostics Market Share by Type (2021-2032) Figure 33. Europe Prostate Cancer Diagnostics Market Share by Application (2021-2032) Figure 34. Europe Prostate Cancer Diagnostics Market Share by Country (2021-2032) Figure 35. Germany Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 36. France Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 38. Italy Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 39. Russia Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 41. China Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 42. China Prostate Cancer Diagnostics Market Share by Type (2021-2032) Figure 43. China Prostate Cancer Diagnostics Market Share by Application (2021-2032) Figure 44. Asia Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 45. Asia Prostate Cancer Diagnostics Market Share by Type (2021-2032) Figure 46. Asia Prostate Cancer Diagnostics Market Share by Application (2021-2032) Figure 47. Asia Prostate Cancer Diagnostics Market Share by Country (2021-2032) Figure 48. Japan Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 52. India Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 53. Australia Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Prostate Cancer Diagnostics Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Prostate Cancer Diagnostics Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Prostate Cancer Diagnostics Market Share by Country (2021-2032) Figure 58. Brazil Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 63. UAE Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 65. Chile Prostate Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Tumor Biomarker Tests
  • Imaging
  • Biopsy
  • Other
Applications
  • Age Below 55
  • Age 55-75
  • Age Above 75
Companies covered
  • OPKO
  • Genomic Health
  • Abbott
  • Beckman Coulter
  • Siemens Healthcare
  • bioMeriux
  • Roche
  • MDx Health
  • DiaSorin
  • Myriad Genetics
  • Ambry Genetics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tumor Biomarker Tests
  5. 1.2.3 Imaging
  6. 1.2.4 Biopsy
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Age Below 55
  11. 1.3.3 Age 55-75
  12. 1.3.4 Age Above 75
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Prostate Cancer Diagnostics Growth Trends by Region
  15. 1.5.1 Global Prostate Cancer Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Prostate Cancer Diagnostics Market Size by Region (2021-2026)
  17. 1.5.3 Prostate Cancer Diagnostics Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Prostate Cancer Diagnostics Market Dynamics
  1. 2.1 Prostate Cancer Diagnostics Industry Trends
  2. 2.2 Prostate Cancer Diagnostics Industry Drivers
  3. 2.3 Prostate Cancer Diagnostics Industry Opportunities and Challenges
  4. 2.4 Prostate Cancer Diagnostics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Prostate Cancer Diagnostics Revenue by Company (2021-2026)
  2. 3.2 Global Prostate Cancer Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Prostate Cancer Diagnostics Key Company Head office and Area Served
  4. 3.4 Global Prostate Cancer Diagnostics Company, Product Type & Application
  5. 3.5 Global Prostate Cancer Diagnostics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Prostate Cancer Diagnostics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Prostate Cancer Diagnostics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Prostate Cancer Diagnostics Tier 1, Tier 2, and Tier 3
4 Prostate Cancer Diagnostics Market by Type
  1. 4.1 Global Prostate Cancer Diagnostics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Prostate Cancer Diagnostics Market Size by Type (2021-2032)
  3. 4.3 Global Prostate Cancer Diagnostics Market Size Share by Type (2021-2032)
5 Prostate Cancer Diagnostics Market by Application
  1. 5.1 Global Prostate Cancer Diagnostics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Prostate Cancer Diagnostics Market Size by Application (2021-2032)
  3. 5.3 Global Prostate Cancer Diagnostics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 OPKO
  2. 6.1.1 OPKO Company Information
  3. 6.1.2 OPKO Business Overview
  4. 6.1.3 OPKO Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 OPKO Prostate Cancer Diagnostics Product Portfolio
  6. 6.1.5 OPKO Recent Developments
  7. 6.2 Genomic Health
  8. 6.2.1 Genomic Health Company Information
  9. 6.2.2 Genomic Health Business Overview
  10. 6.2.3 Genomic Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Genomic Health Prostate Cancer Diagnostics Product Portfolio
  12. 6.2.5 Genomic Health Recent Developments
  13. 6.3 Abbott
  14. 6.3.1 Abbott Company Information
  15. 6.3.2 Abbott Business Overview
  16. 6.3.3 Abbott Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Abbott Prostate Cancer Diagnostics Product Portfolio
  18. 6.3.5 Abbott Recent Developments
  19. 6.4 Beckman Coulter
  20. 6.4.1 Beckman Coulter Company Information
  21. 6.4.2 Beckman Coulter Business Overview
  22. 6.4.3 Beckman Coulter Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
  24. 6.4.5 Beckman Coulter Recent Developments
  25. 6.5 Siemens Healthcare
  26. 6.5.1 Siemens Healthcare Company Information
  27. 6.5.2 Siemens Healthcare Business Overview
  28. 6.5.3 Siemens Healthcare Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
  30. 6.5.5 Siemens Healthcare Recent Developments
  31. 6.6 bioMeriux
  32. 6.6.1 bioMeriux Company Information
  33. 6.6.2 bioMeriux Business Overview
  34. 6.6.3 bioMeriux Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 bioMeriux Prostate Cancer Diagnostics Product Portfolio
  36. 6.6.5 bioMeriux Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Roche Prostate Cancer Diagnostics Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 MDx Health
  44. 6.8.1 MDx Health Company Information
  45. 6.8.2 MDx Health Business Overview
  46. 6.8.3 MDx Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 MDx Health Prostate Cancer Diagnostics Product Portfolio
  48. 6.8.5 MDx Health Recent Developments
  49. 6.9 DiaSorin
  50. 6.9.1 DiaSorin Company Information
  51. 6.9.2 DiaSorin Business Overview
  52. 6.9.3 DiaSorin Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 DiaSorin Prostate Cancer Diagnostics Product Portfolio
  54. 6.9.5 DiaSorin Recent Developments
  55. 6.10 Myriad Genetics
  56. 6.10.1 Myriad Genetics Company Information
  57. 6.10.2 Myriad Genetics Business Overview
  58. 6.10.3 Myriad Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
  60. 6.10.5 Myriad Genetics Recent Developments
  61. 6.11 Ambry Genetics
  62. 6.11.1 Ambry Genetics Company Information
  63. 6.11.2 Ambry Genetics Business Overview
  64. 6.11.3 Ambry Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
  66. 6.11.5 Ambry Genetics Recent Developments
7 North America
  1. 7.1 North America Prostate Cancer Diagnostics Market Size (2021-2032)
  2. 7.2 North America Prostate Cancer Diagnostics Market Size by Type
  3. 7.2.1 North America Prostate Cancer Diagnostics Market Size by Type (2021-2026)
  4. 7.2.2 North America Prostate Cancer Diagnostics Market Size by Type (2027-2032)
  5. 7.2.3 North America Prostate Cancer Diagnostics Market Share by Type (2021-2032)
  6. 7.3 North America Prostate Cancer Diagnostics Market Size by Application
  7. 7.3.1 North America Prostate Cancer Diagnostics Market Size by Application (2021-2026)
  8. 7.3.2 North America Prostate Cancer Diagnostics Market Size by Application (2027-2032)
  9. 7.3.3 North America Prostate Cancer Diagnostics Market Share by Application (2021-2032)
  10. 7.4 North America Prostate Cancer Diagnostics Market Size by Country
  11. 7.4.1 North America Prostate Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Prostate Cancer Diagnostics Market Size by Country (2021-2026)
  13. 7.4.3 North America Prostate Cancer Diagnostics Market Size by Country (2027-2032)
  14. 7.4.4 North America Prostate Cancer Diagnostics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Prostate Cancer Diagnostics Market Size (2021-2032)
  2. 8.2 Europe Prostate Cancer Diagnostics Market Size by Type
  3. 8.2.1 Europe Prostate Cancer Diagnostics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Prostate Cancer Diagnostics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Prostate Cancer Diagnostics Market Share by Type (2021-2032)
  6. 8.3 Europe Prostate Cancer Diagnostics Market Size by Application
  7. 8.3.1 Europe Prostate Cancer Diagnostics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Prostate Cancer Diagnostics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Prostate Cancer Diagnostics Market Share by Application (2021-2032)
  10. 8.4 Europe Prostate Cancer Diagnostics Market Size by Country
  11. 8.4.1 Europe Prostate Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Prostate Cancer Diagnostics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Prostate Cancer Diagnostics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Prostate Cancer Diagnostics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Prostate Cancer Diagnostics Market Size (2021-2032)
  2. 9.2 China Prostate Cancer Diagnostics Market Size by Type
  3. 9.2.1 China Prostate Cancer Diagnostics Market Size by Type (2021-2026)
  4. 9.2.2 China Prostate Cancer Diagnostics Market Size by Type (2027-2032)
  5. 9.2.3 China Prostate Cancer Diagnostics Market Share by Type (2021-2032)
  6. 9.3 China Prostate Cancer Diagnostics Market Size by Application
  7. 9.3.1 China Prostate Cancer Diagnostics Market Size by Application (2021-2026)
  8. 9.3.2 China Prostate Cancer Diagnostics Market Size by Application (2027-2032)
  9. 9.3.3 China Prostate Cancer Diagnostics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Prostate Cancer Diagnostics Market Size (2021-2032)
  2. 10.2 Asia Prostate Cancer Diagnostics Market Size by Type
  3. 10.2.1 Asia Prostate Cancer Diagnostics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Prostate Cancer Diagnostics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Prostate Cancer Diagnostics Market Share by Type (2021-2032)
  6. 10.3 Asia Prostate Cancer Diagnostics Market Size by Application
  7. 10.3.1 Asia Prostate Cancer Diagnostics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Prostate Cancer Diagnostics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Prostate Cancer Diagnostics Market Share by Application (2021-2032)
  10. 10.4 Asia Prostate Cancer Diagnostics Market Size by Country
  11. 10.4.1 Asia Prostate Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Prostate Cancer Diagnostics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Prostate Cancer Diagnostics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Prostate Cancer Diagnostics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Prostate Cancer Diagnostics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Prostate Cancer Diagnostics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Prostate Cancer Diagnostics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst